BioNTech SE (VIE:BNTX)
96.05
+0.15 (0.16%)
Last updated: Aug 28, 2026, 1:00 PM CET
BioNTech SE Revenue
BioNTech SE had revenue of 145.80M EUR in the quarter ending June 30, 2026, a decrease of -56.99%. This brings the company's revenue in the last twelve months to 2.43B, down -15.71% year-over-year. In the year 2025, BioNTech SE had annual revenue of 3.05B with 5.63% growth.
Revenue (ttm)
2.43B
Revenue Growth
-15.71%
P/S Ratio
8.34
Revenue / Employee
339.44K
Employees
7,807
Market Cap
22.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.05B | 162.80M | 5.63% |
| Dec 31, 2024 | 2.89B | -1.03B | -26.31% |
| Dec 31, 2023 | 3.92B | -13.39B | -77.33% |
| Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
| Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
| Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
| Dec 31, 2019 | 108.60M | -18.98M | -14.87% |
| Dec 31, 2018 | 127.58M | 65.98M | 107.11% |
| Dec 31, 2017 | 61.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| OMV Aktiengesellschaft | 25.61B |
| Strabag SE | 18.72B |
| Voestalpine AG | 15.16B |
| Vienna Insurance Group AG | 14.32B |
| Erste Group Bank AG | 13.11B |
| Raiffeisen Bank International AG | 8.88B |
| Andritz AG | 8.07B |
| VERBUND AG | 7.59B |
BioNTech SE News
- 14 hours ago - BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why - TipRanks
- 14 hours ago - Cevumeran trial termination a ‘clear setback’ for BioNTech, says BMO Capital - TheFly
- 15 hours ago - mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley - TheFly
- 17 hours ago - BioNTech to terminate mid-stage trial of mRNA cancer vaccine - Reuters
- 17 hours ago - BioNTech drops 9% after ending Phase 2 colorectal cancer trial - TheFly
- 17 hours ago - BioNTech to terminate Phase 2 monotherapy trial of cevumeran - TheFly
- 1 day ago - US FDA approves updated COVID vaccines for 2026-27 season - Reuters
- 1 day ago - Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine - TheFly